Skip to main content
Signal8

Smith Edward F

SEC insider (Form 3/4/5 filer). CIK 0001368350. Director at Benitec Biopharma Inc. (BNTC). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 1, 2025. Located in HAYWARD, CA.

Companies Smith Edward F has filed insider reports for

  • Benitec Biopharma Inc. (BNTC): Director
Smith Edward F profile photo

Smith Edward F

CIK: 0001368350

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Benitec Biopharma Inc. logo
BNTC

Benitec Biopharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Benitec Biopharma Inc. logo
    BNTC

    Benitec Biopharma Inc.

    Dec 1, 2025
    Award

    Options (right to buy)

    Direct
    35K shares-
  • Benitec Biopharma Inc. logo
    BNTC

    Benitec Biopharma Inc.

    Dec 9, 2024
    Award

    Options (right to buy)

    Direct
    35K shares-

1-2 of 2